Fenyloketonuria: badanie kliniczne
The Impact of Frequency of Home Phenylalanine Measurements on Metabolic Control in a Population of Patients With Classic Phenylketonuria
Badania kliniczne w Polsce dotyczące chorób rzadkich, czyli występujących u mniej niż 5 na 10 000 osób. Dla wielu z nich badanie kliniczne to jedyna droga do nowego leczenia.
24 badania w Polsce: 24 rekrutują. Ośrodki w 17 miastach.
The Impact of Frequency of Home Phenylalanine Measurements on Metabolic Control in a Population of Patients With Classic Phenylketonuria
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria
Low dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease – prospective randomized controlled…
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
Evaluation of the Efficacy of Valsartan in Slowing Down Aortic Root Dilatation in Children and Young Adults with Marfan-type Heritable Thoracic Aortic Diseases – Valsar-TAD, a…
Phase 2a non-commercial and non-randomized intervention study evaluating the efficacy of crizotinib in the treatment of children with severe type 2 neurofibromatosis, in…
MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU)…
A Study of Pitolisant in Patients With Prader-Willi Syndrome
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
A Global Prospective Observational Registry of Patients With Pompe Disease
Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects
Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
Według daty pojawienia się badania w rejestrze (CTIS lub ClinicalTrials.gov).
Zadzwoń i porozmawiaj z doradcą ds. badań klinicznych. Sprawdzimy w rejestrach, do których badań możesz się kwalifikować.
Nie udzielamy porad ani konsultacji medycznych. Pomagamy znaleźć badanie i skontaktować się z ośrodkiem.
Informacje pochodzą z publicznych rejestrów badań klinicznych (CTIS - Unia Europejska, ClinicalTrials.gov - USA) i są aktualizowane codziennie. Mogą różnić się od aktualnego stanu w ośrodku. Ostateczną kwalifikację do badania zawsze przeprowadza lekarz w ośrodku badawczym. Stan na 17 listopada 2026.